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a b s t r a c t
The authors report a case of superficial acral fibromyxioma (SAF) in a 74-year-old male 
who presented with a painless mass in a periungual dorsoradial region of the right thumb. 
It is a rare benign neoplasm, which was recently described, that arouse on the skin and 
subcutaneous tissue of the hands and feet, especially in the proximity to the ungual 
region of male adults. Surgical treatment was performed with the excision in blocks of 
the margins of the lesion and fragmentation of the nail and nail matrix, according to the 
literature recommendation. Although there may be local recurrence in 22% of the cases, the 
patient presents no symptoms, deformities or functional limitations. In addition, there was 
no sign of tumor recurrence 18 months after the surgery. We are not aware of a similar case 
report in the Brazilian literature. 
© 2013 Sociedade Brasileira de Ortopedia e Traumatologia. Published by Elsevier Editora 
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Introduction
Superficial acral fibromyxoma (SAF) is a myxoid tumor that was 
recently described by Fetsch et al.,1 which preferentially affects 
the subungual or periungual region. It is generally manifested 
in the form of a slow-growing painless mass that mainly affects 
male adults. With regard to histological analysis, it presents 
as a poorly delineated neoplasm composed of fusiform or 
stellate neoplastic cells with a varying degree of pleomorphism, 
located in myxoid and collagenous stroma. The fusiform cells 
present immunoreactivity to CD34, CD99, vimentin and, focally, 
to the epithelial membrane antigen (EMA). Blood vessels are 
predominantly found in the myxoid area and mast cells tend 
to be distributed throughout the lesion. In most cases, the 
prognosis is benign, although there have been reports of cases 
with local recurrence.2
Dissemination of cases of this tumor serves the purpose 
of informing surgeons and pathologists about the correct 
diagnosis for these lesions, since this is a rare tumor that is 
liable to recur. Its differential diagnoses include malignant 
tumors such as dermatofibrosarcoma protuberans and 
dermatofibrosarcoma myxoid.3-5 
Case report
The patient was a 74-year-old man with slightly painful 
tumor growth in the dorsoradial periungual region of the 
right thumb that had progressively been increasing in size 
over approximately the last 10 years. The patient was retired 
and had previously been a farm laborer. He reported that he 
had had two previous episodes of trauma at the site where 
the tumor growth had formed, resulting in ulceration followed 
by rapid healing. The data relating to the patient’s previous 
pathological, social and family histories did not contain any 
elements of relevance to the diagnosis.
The physical examination revealed a periungual tumor in 
the dorsoradial region of the right thumb, of oval shape, which 
medially pushed back the nail, ungual matrix and cuticle. At 
the center of the lesion, an epithelized depression was evident, 
suggesting previous ulceration (Fig. 1). The tumor had firm 
consistency and was adhering to the deep layers; it was slightly 
painful on palpation. The thumb presented complete perfusion 
without signs of increased local vascularization or any other 
phlogistic sign. Transillumination confirmed the solid nature 
of the lesion. There were no abnormalities of thumb mobility. 
The patient complained of local hyperesthesia on palpation 
and was Tinnel negative. 
Simple radiography showed tumor growth, with density 
similar to the adjacent soft tissues, without calcifications and 
without bone erosion, deformity or periosteal reaction. 
The lesion was resected en-bloc, with nail and matrix 
fragments, under trunk anesthetic block. The excision was 
intended to be marginal, since it was suspected that this was a 
benign lesion. Even so, it was necessary to deepen the incision 
down to the bone phalange, and a local cutaneous flap had to 
be rotated into position, in order to achieve primary closure 
of the lesion.
Fig. 1 - Preoperative images of the right thumb showing 
voluminous tumor growth on the dorsoradial edge of the 
thumb. From the upper left corner, clockwise: dorsal view, 
ulnar view, palmar view and radial view.
Fig. 2 - Superficial acral fibromyxoma. Macroscopic 
appearance: specimen removed en-bloc, showing 
superficial face with fragment of nail adhering to it.
Fig. 4 - Superficial acral fibromyxoma. Histopathological 
analysis showing well delimited fibromyxoid neoplasm, 
partially covered with hyperplastic epidermis, with 
hyperkeratosis. HE, 100x.
Fig. 3 - Superficial acral fibromyxoma. Macroscopic 
appearance: specimen removed en-bloc, showing 
underside with subcutaneous tissue adhering to it.
202 Rev Bras Ortop. 2013;48(2):200-203
The macroscopic examination showed that the specimen 
was a discoid tissue fragment of 1.6 cm in diameter and 1.0 cm 
in depth, with a face consisting of tumor surface with a nail 
fragment adhering to it (Fig. 2) and an underside covered with 
subcutaneous tissue (Fig. 3). Examination under a microscope 
showed ulceration with stromal invasion by the neoplasm. 
The tissue proliferation also involved the dermis and the 
subcutaneous tissue, and comprised stellate and fusiform 
cells distributed in a collagenized matrix, with myxoid areas 
(Fig. 4). A rich vascular network, discrete nuclear atypia and 
rate mitosis figures were seen (Fig. 5). Immunohistochemical 
analysis showed CD34 expression, but the specimen was 
negative for smooth muscle actin, EMA, desmin, protein S-100 
and CD63. The clinical and anatomopathological findings 
confirmed the diagnosis of SAF.
After 18 months of follow-up, the patient continues to be 
asymptomatic, without deformities or functional limitations, 
and without signs of tumor recurrence (Fig. 6).
Discussion
SAF was originally described by Fetsch et al.1 in 2001, and is 
a benign neoplasm of the skin and subcutaneous tissue that 
is considered to be rare. It usually affects the extremities of 
the fingers and toes. On rare occasions, SAF affects other 
locations: it has been reported on the palm of the hand and 
the calcaneus.6 Although it is considered to be benign, it may 
recur locally in up to 22% of the cases.6 No cases of distant 
metastasis have been reported in the literature. Although it 
was initially reported as a very rare tumor,1 some more recent 
reports have suggested that this tumor is less rare but very 
likely to be underdiagnosed.5-8 In fact, in a survey that we 
conducted in PubMed, we only found 18 reports of tumors of 
this type, and none of these reports form part of the Brazilian 
literature.
Several authors have emphasized that the diagnosis of 
unspecified myxoma should no longer be used,6,7 considering 
that differentiation of the specific tumor types is now possible 
and makes it possible to identify cases with the potential 
for recurrence, as is the case of SAF.1,2 Moreover, precise 
histopathological diagnosis may avoid cases of unnecessarily 
aggressive treatment. In the original report by Fetsch et al.,1 four 
of the 37 specimens studied originated from partial amputation 
of the fingers. Today, limb preservation is recommended in 
treating SAF, such that the primary objective should be en-bloc 
resection with disease-free margins.7,9,10
The present case required rotation of a local cutaneous 
flap in order to cover the bone. Other differential diagnoses 
for SAF include epidermal inclusion cyst, glomus tumor, 
fibrous histiocytoma, acquired digital fibrokeratoma, 
sclerosing perineuroma, superficial angiomyxoma, acral 
myxoinflammatory fibroblastic sarcoma and several other 
low-grade myxoid sarcomas.1-7,9,10 The difficulty in coming 
to a diagnostic conclusion generally lies in the relative 
lack of knowledge of this lesion among many pathologists, 
dermatologists and hand surgeons.7 Prescott et al. discussed 
this matter in a paper that reported 41 new cases of SAF that 
were diagnosed retrospectively.7 These tumors had previously 
been labeled as myxoma, fibroma or dermatofibroma. These 
authors questioned the validity of this type of generic diagnosis 
in the present century, given that immunohistochemical 
markers are now available and are capable of differentiating 
between specific tumor types, often with important clinical 
implications for treatment and prognosis.6,7 In our case, the 
initial diagnosis was inconclusive and a consultation office 
with a specialist pathologist and immunohistochemical tests 
furnished the definitive diagnosis.
The clinical data on our patient illustrate the typical 
presentation of these tumors. In the literature, the region most 
affected is the distal extremity of the fingers and toes.1,2,5-10 In 
one series, involvement of the ungual plate was observed in 
75% of the cases.7 In the majority of the series, there was greater 
occurrence among male adults. The length of evolution of these 
tumors has been reported as ranging from three months to 
30 years.2 The mean size of the lesions ranges from 1.5 to 
2 cm,1,7 although cases of between 0.6 and 5 cm in diameter 
have been reported.1 The radiographic findings from these 
Fig. 5 - Superficial acral fibromyxoma. Histopathological 
analysis showing elongated neoplastic cells without atypias, 
with myxoid stroma and rich vascularization. HE, 200x.
Fig. 6 - Postoperative images of the right thumb showing 
adequate healing, with good cosmetic result and without 
signs of recurrence. From the upper left corner, clockwise: 
dorsal view, ulnar view, palmar view and radial view.
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tumors are generally nonspecific, with increased soft-tissue 
volume and absence of calcifications. It can be noted that all 
of the abovementioned characteristics were corroborated in 
our patient. However, bone erosion may also be present and 
has been reported by several authors.11,12 In the majority of 
the cases, the mass is painless, although painfulness may be 
noted in up to 10% of the cases.7,9
Histologically, SAF consists of moderate proliferation 
of fusiform fibroblasts and stellate cells inside a myxoid, 
myxocollagenous or collagenous matrix. A rich microvascular 
network and local mast cell infiltration are often seen in the 
tumor. The cells present a pattern of storiform, irregular and 
fascicular growth, with rare findings of mitosis figures and 
nuclear atypia.1-3 Immunohistochemistry is important for the 
diagnosis and shows positive findings for CD34, CD99 and EMA 
(epithelial membrane antigen) and negative findings for S-100, 
cytokeratin, smooth muscle, skeletal muscle and melanocytic 
markers.1,3,4,6,8
The natural history of this neoplasm indicates that its 
evolution is benign, although the histology of the tumor may 
vary from mild cellular atypia to marked nuclear atypia, with 
many mitosis figures in rare cases.1 In this situation, there 
is some concern regarding the possible risk of low-grade 
malignant transformation.5,9 For this reason, the preferred 
treatment is complete surgical resection with free margins. 
Thus, through this, disastrous events with an impact on such 
patients can be minimized with the perception of a correct 
diagnosis and consequent appropriate management. The 
present case continues under observation, since recurrences 
have been reported in such cases up to one year and eight 
months after the surgery.2
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